2016
DOI: 10.1007/s00418-016-1454-3
|View full text |Cite
|
Sign up to set email alerts
|

Short SULF1/SULF2 splice variants predominate in mammary tumours with a potential to facilitate receptor tyrosine kinase-mediated cell signalling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 35 publications
0
10
0
Order By: Relevance
“…93 Dhoot et al demonstrated that SULF2 can be expressed as an alternatively spliced catalytically inactive variant and found that various tumors express this at high levels. [94][95][96] Mechanistically, the inactive variant titrates out the active variant and results in an increase in 6-O sulfation and receptor tyrosine kinase activation. It would thus also be important to check which splice variants of SULF2 are expressed in macrophages and other immune cell types during chronic inflammation.…”
Section: Sulfatasesmentioning
confidence: 99%
“…93 Dhoot et al demonstrated that SULF2 can be expressed as an alternatively spliced catalytically inactive variant and found that various tumors express this at high levels. [94][95][96] Mechanistically, the inactive variant titrates out the active variant and results in an increase in 6-O sulfation and receptor tyrosine kinase activation. It would thus also be important to check which splice variants of SULF2 are expressed in macrophages and other immune cell types during chronic inflammation.…”
Section: Sulfatasesmentioning
confidence: 99%
“…Tissue sections for morphological observations were stained with a standard haematoxylin and eosin stain. Double immunofluorescent procedure as described previously 14 was used to evaluate the cellular phenotypes of normal and 15 HCC tissues. Following commercial antibodies were used for this analysis: Wnt2 (Prestige)-1/150, active caspase-3 (R&D)-1/100, ptc1 (Millipore)-1/300, p-Smad1,5,8 (Cell signalling)-1/300, HIF1α (Novus)-1/40, EpoR (Abcam)-1/250, Glycophorin A (Abcam)-1/10, Cytokeratin 18 (Abcam)-1/300, smooth muscle α-actin (IA4)-1/400, vWF 15 (Dako)-1/200, rabbit anti CD146 (Sigma)-1/200, mouse anti NANOG (Abcam)-1/100 and rabbit anti OCT4 (Novus biologicals)-1/100.…”
Section: Methodsmentioning
confidence: 99%
“…With the exception of Glycophorin A antibody that itself is linked to 488 fluorochrome, the binding of all other antibodies was detected by secondary antibodies linked to 488 (green) fluorochrome or 594 (red) fluorochrome as previously described. 14 Immunoperoxidase staining was used to detect the expression pattern of active-β-catenin (Millipore) antibody using 1/100 dilution as previously described. 16…”
Section: Methodsmentioning
confidence: 99%
“…However, ligands are often sequestered in the extracellular matrix (ECM) which need to be liberated for them to activate their receptor. We have previously shown that de-sulfation of the ECM mediated by SULF1/SULF2 enzymes regulates signalling pathways during development, regeneration and disease [1,[9][10][11].…”
Section: Introductionmentioning
confidence: 99%